Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects
NCT05298332
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
37
Enrollment
INDUSTRY
Sponsor class
Stopped
Terminated by the Sponsor
Conditions
Chronic Hepatitis b
Interventions
DRUG:
ATI-2173 50 mg
Sponsor
Antios Therapeutics, Inc